KANNAPOLIS —Samples and data from the MURDOCK Study — the groundbreaking community-based biorepository at Duke Kannapolis — helped to accelerate a recent heart failure discovery by Duke University researchers.
Duke Clinical & Translational Science Institute
Duke-Kannapolis launches kidney disease study for people of African descent April 14, 2021
Dr. Opeyemi Olabisi (second from left), principal investigator for the Duke APOL1 Study, joins the Duke CTSI TransPop team for the study launch in Kannapolis.
Through her participation in COVID-19 research with the Duke Clinical and Translational Science Institute (CTSI), Connelia Houston learned about a new study in Kannapolis for people of African descent.
The Duke APOL1 Study at the N.C. Research Campus needs people like Houston who are 50 or older, have African ancestry and do not have kidney disease, diabetes or HIV. Houston, an attorney in Charlotte who lives in Harrisburg, decided to enroll.